Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down.
礼来礼来(US:LLY) MarketWatch·2026-01-05 23:57

公司产品与市场地位 - 诺和诺德公司旗下广受欢迎的肥胖症治疗药物现已推出口服剂型 [1] - 该口服药物成为美国市场首款用于减重的GLP-1片剂 [1]

Novo Nordisk's weight-loss pill is available. Here's why Lilly's and Viking's stocks are down. - Reportify